文献速递细菌感染、耐药与抗菌药物

低中收入国家的抗生素管理:相同但不同?

Antibiotic stewardship in low- and middle-income countries: the same but different?
PubMed 文献 · Clin Microbiol Infect · 2017-07-14

本文综述低中收入国家抗生素管理面临的挑战与可行干预。尽管证据有限且实施障碍多,拉丁美洲、非洲和亚洲的国际与地方举措显示有效干预可行,但需结合情境。建议制定针对低中收入国家建立抗生素管理项目的具体指南。

要点

  • 低中收入国家抗生素管理证据有限,实施挑战多。
  • 国际与地方举措显示有效干预可行,但需情境化。
  • 建议逐步解决诊断可及性、教育、监管等战略要点。

核心结论

  • 低中收入国家抗生素管理有效干预可行,但需结合情境。
  • 应制定针对低中收入国家建立抗生素管理项目的具体指南。

研究设计与样本

  • 综述:检索PubMed中低中收入国家人类抗生素管理干预文章,并咨询相关网站与专家。

主要发现

  • 低中收入国家有效可行抗生素管理干预证据有限,实施挑战众多。
  • 拉丁美洲、非洲和亚洲的国际与地方举措显示有效干预可行。

关键数值与推荐

  • 战略要点包括确保诊断检测可及性、提供抗生素耐药教育、创建或加强监管机构、强化医疗机构、探索多方协同、设计易扩展干预。

临床怎么用

  • 在低中收入国家实施抗生素管理需结合当地情境,逐步推进战略要点。

局限性

  • 低中收入国家有效可行抗生素管理干预证据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Antibiotic resistance (ABR) is a quickly worsening problem worldwide, also in low- and middle-income countries (LMICs). Appropriate antibiotic use in humans and animals, i.e. antibiotic stewardship (ABS), is one of the cornerstones of the World Health Organization's global action plan for ABR. Many LMICs are in the process of developing stewardship programs. AIMS: We highlight challenges for ABS initiatives in LMICs, give an outline of (inter)national recommendations and demonstrate examples of effective, contextualized stewardship interventions. SOURCES: We searched PubMed for articles on ABS interventions in humans in LMICs. Relevant websites and experts were consulted for additional sources. CONTENT: Evidence on effective and feasible stewardship interventions in LMICs is limited, and challenges for implementation of interventions are numerous. Nevertheless, several initiatives at the international and local levels in Latin America, Africa and Asia have shown that ABS effective interventions are feasible in LMICs, although contextualization is essential. IMPLICATIONS: Specific guidance for setting up antimicrobial stewardship programs in LMICs should be developed. Strategic points might need to be progressively addressed in LMICs, such as (a) ensuring availability of diagnostic testing, (b) providing dedicated education in ABR both for healthcare workers and the general public, (c) creating or strengthening (inter)national agencies towards better regulations and audit on production, distribution and dispensing of drugs, (d) strengthening healthcare facilities, (e) exploring a broader synergism between policy makers, academia, professional bodies and civil society and (f) designing and studying easy and scalable ABS interventions for both hospital and community settings.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Cox JA, Vlieghe E, Mendelson M, et al. Antibiotic stewardship in low- and middle-income countries: the same but different? Clin Microbiol Infect. 2017. PMID: 28712667. doi:10.1016/j.cmi.2017.07.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。